Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin after endovascular thrombectomy for acute anterior circulation ischemic stroke
NL-OMON59588Phase 2Recruiting
- Sponsor
- Rijnstate
- Start
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of human ghrelin in ischemic stroke (2 arms), sponsored by Rijnstate. Primary endpoint: NIHSS score at 7 days or discharge. Started Nov 2024; status: recruiting.
02
Drugs
human ghrelin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON59588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59588.